TFE3 and carcinoma: Taking all ASPSCR1-TFE3 and PRCC-TFE3 carcinomas into consideration, 7/16 (43.8%) T1a tumors and 6/12 (50.0%) T1b tumors showed regional lymph node involvement, which is consistent with our data.